EUVIMEDEUVIMED entdecken
Open Access

Pathway-Based Classification of Lung Cancer: A Strategy to Guide Therapeutic Selection

Joseph R Nevins

Proceedings of the American Thoracic Society · 01.05.2011 · 8 (2) · 180-182

DOI: 10.1513/pats.201006-040ms ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the American Thoracic Society, online erschienen am 01.05.2011. Verfasst von Joseph R Nevins. Beteiligte Einrichtung: Duke Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, NC 27708, USA. j.nevins@duke.edu. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The critical challenge in virtually all cancer research is heterogeneity: “Breast cancer” and “lung cancer” are actually collections of disease with distinct molecular mechanisms and clinical characteristics. The challenge is evident in the complexity of most cancers with multiple mutations and alterations generating the cancer phenotype, requiring therapeutic strategies that can match the complexity with equally complex combination regimens. Substantial progress in treatment requires major advances in methods to define refined, “common mechanism” subgroups to allow development of combination therapeutics that target these individual mechanisms. Our work is on the use of genomic signatures of oncogenic signaling pathways that provide an opportunity to dissect the complexity of lung cancer and to serve as tools to direct the use of targeted therapeutic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCarcinoma, Non-Small-Cell LungCell Line, TumorGene Expression ProfilingHumansLung NeoplasmsSignal Transduction

Autor:innen und Institutionen

  • Duke Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, NC 27708, USA. j.nevins@duke.edu

Förderung

  • NCI NIH HHS

Zitieren

APA

Nevins, J. R. (2011). Pathway-Based Classification of Lung Cancer: A Strategy to Guide Therapeutic Selection. Proceedings of the American Thoracic Society, 8(2), 180-182. https://doi.org/10.1513/pats.201006-040ms

Vancouver

Nevins JR. Pathway-Based Classification of Lung Cancer: A Strategy to Guide Therapeutic Selection. Proceedings of the American Thoracic Society. 2011;8(2):180-182. doi:10.1513/pats.201006-040ms

BibTeX
@article{Nevins2011,
  author = {Nevins, Joseph R},
  title = {Pathway-Based Classification of Lung Cancer: A Strategy to Guide Therapeutic Selection},
  journal = {Proceedings of the American Thoracic Society},
  year = {2011},
  volume = {8},
  number = {2},
  pages = {180--182},
  doi = {10.1513/pats.201006-040ms}
}
Kostenlos starten →